The Efficacy of Clearblue's Menopause At-Home Test: A Closer Look

Clearblue, the maker of pregnancy tests, has released an at-home menopause test kit in the United States. The test, which costs between $20 and $30, detects high levels of follicular stimulating hormone (F.S.H.) associated with the transition to menopause. While some experts are skeptical about its accuracy, others believe it could provide additional data points for women experiencing early stages of menopause. The test requires five urine samples over 10 days and users enter the results into a Clearblue app, which tracks symptoms and determines the stage of menopause transition. However, the company advises users to consult healthcare providers for confirmation and further guidance.
Reading Insights
0
1
4 min
vs 5 min read
89%
931 → 104 words
Want the full story? Read the original article
Read on The New York Times